Clinical utility of a molecular signature in inflammatory demyelinating disease

OBJECTIVE: We sought to develop molecular biomarkers of intrathecal inflammation to assist neurologists in identifying patients most likely to benefit from a range of immune therapies. METHODS: We used Luminex technology and index determination to search for an inflammatory activity molecular signat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pachner, Andrew R., DiSano, Krista, Royce, Darlene B., Gilli, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278854/
https://www.ncbi.nlm.nih.gov/pubmed/30568998
http://dx.doi.org/10.1212/NXI.0000000000000520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278854/
https://www.ncbi.nlm.nih.gov/pubmed/30568998
http://dx.doi.org/10.1212/NXI.0000000000000520

Ejemplares similares